Nucleic Acids Research 27:3792-3798 (1999)
© 1999 Oxford University Press
Article |
Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency
UMR 133 Centre National de la Recherche ScientifiqueRhône Poulenc Rorer and 1Rhône Poulenc RorerGencell Vector Development, CRVA, 13 Quai Jules Guesde, BP 14, 94403 Vitry sur Seine, France and 2Rhodia, CRA, 52 Rue de la Haie Coq, 93308 Aubervilliers, France
| ABSTRACT |
|---|
|
|
|---|
Clinical applications of gene therapy mainly depend on the development of efficient gene transfer vectors. Large DNA molecules can only be transfected into cells by using synthetic vectors such as cationic lipids and polymers. The present investigation was therefore designed to explore the physicochemical properties of cationic lipidDNA particles, with plasmids ranging from 900 to 52 500 bp. The colloidal stability of the lipoplexes formed by complexing lipopolyamine micelles with plasmid DNA of various lengths, depending on the charge ratio, resulted in the formation of three domains, respectively corresponding to negatively, neutrally and positively charged lipoplexes. Lipoplex morphology and structure were determined by the physicochemical characteristics of the DNA and of the cationic lipid. Thus, the lamellar spacing of the structure was determined by the cationic lipid and its spherical morphology by the DNA. The main result of this study was that the morphological and structural features of the lipopolyamineDNA complexes did not depend on plasmid DNA length. On the other hand, their gene transfer capacity was affected by the size of plasmid DNA molecules which were sandwiched between the lipid bilayers. The most effective lipopolyamineDNA complexes for gene transfer were those containing the shortest plasmid DNA.
| INTRODUCTION |
|---|
|
|
|---|
Viral vectors can mediate efficient gene transfer. However, three factors may significantly limit their clinical application: (i) viral-related immunogenicity; (ii) the potential risk associated with replication-competent virus; and (iii) the size limitation of the transgene. As an alternative, non-viral vectors, i.e. plasmid DNA, either naked or complexed with cationic molecules, have also been used for gene transfer in clinical trials. Despite encouraging results, non-viral vectors remain less efficient for transfection than viruses. A better understanding of the lipoplex and polyplex structures involved in their biological activity, cellular entry and nuclear import of plasmid DNA might improve their efficacy for transfection.
The supramolecular structure of cationic lipidDNA lipoplexes was recently reported for some formulations. For instance, lipid bilayer covered DNA tubules were found after the addition of DNA to cationic liposomes consisting of 3-ß-[N-(N",N"-dimethylethane)carbamoyl] cholesterol/dioleoyl phosphatidylethanolamine (DC-Chol/DOPE) (1). In contrast, the addition of linear or circular DNA to cationic liposomes of dioleoyl trimethylammonium propane/DOPE (DOTAP/DOPE) (2) and of dioctadecyldiammonium bromide/cholesterol (DODAB/Chol) (3) was shown to induce a topological transition from unilamellar vesicles into a higher order multilamellar structure in which DNA is sandwiched between lipid bilayers. In the latter two reports a multilamellar organization with a regular spacing of 65 Å was reported after DNA had been mixed with unilamellar vesicles of quaternary ammonium lipids, i.e. lipids bearing a single positive charge per molecule, combined with a neutral lipid or cholesterol. In a previous work, structural analysis of lipoplexes resulting from the association of plasmid DNA with a lipopolyamine, i.e. RPR120535, containing three positive charges at neutral pH showed that plasmid DNA transformed multivalent cationic lipid micelles into a supramolecular organization characterized by fully condensed DNA inside spherical particles (diameter 50 nm) resulting in a local lamellar organization with a spacing of 80 Å (4).
Despite the great efforts made to understand the physicochemical properties of the cationic lipidDNA lipoplexes used in non-viral gene therapy (57), very little is known about the effect of DNA plasmid length on the ultrastructural features of these lipoplexes and its action on their gene transfer activity. However, in the near future, it will be of crucial importance to develop systems capable of transducing large DNA fragments into cells. For example, plasmovirus technology (8) and the development of regulatory systems for gene expression induced by agents like tetracycline or rapamycin are based on the transfection of large DNA molecules into cells (9,10). On the other hand the length of human dystrophin cDNA (14 000 bp) prevents it from being introduced into currently used viral vectors, thus necessitating the use of the less efficient 6000 bp minidystrophin cDNA (11,12).
The objective of this study was to apply a previously described methodology (4), designed to provide a simple way of producing small cationic lipidDNA lipoplexes with rigorous physicochemical characterization, to plasmid DNA of various sizes ranging from 900 to 52 500 bp. We therefore explored the correlation between the physicochemical properties of lipopolyamineDNA complexes and transfection activity, because these structurefunction relationships are of crucial importance for the future development of cationic lipid-mediated gene delivery.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Polyanions and plasmids
Sodium hexametaphosphate was provided by Europhos (Engis, Belgium).
Plasmid construction and isolation, bacterial transformation and DNA analysis were performed as already described (13). Plasmids pXL3178 (900 bp) and pXL3032 (3700 bp) were both pCOR (plasmid with a conditional origin of replication) containing the
origin of replication, the cer element from the ColE1 site-specific recombination system and the supPhe selectable marker as previously described (14). Plasmid pXL3032 contained a 2600 bp luciferase expression cassette containing: (i) the pCMV promoter completed by the 5" Herpes simplex thymidine kinase untranslated leader (15); (ii) the modified firefly luciferase gene (luc+) from pGL3 Basic (Promega Corp., Madison, WI); and (iii) the simian virus SV40 late polyadenylation signal, also obtained from pGL3. Plasmid pXL3326 was generated by inserting the 2600 bp BamHISwaI luciferase expression cassette into pXL2777 (16) cut by BamHI and EcoRV. Plasmid pXL3108 (8600 bp) was a plasmid used for adenoviral vector construction and contains the adenoviral ITR and pIX sequences (10). Plasmid pXL3340 (19 600 bp) is a derivative of pXL59 (17). Plasmid pXL3141 (52 500 bp) was a recombinant adenoviral plasmid vector (10). Plasmids pXL3108, pXL3340 and pXL3141 all contained the same luciferase expression cassette as described above. A minicircle (2900 bp) containing this cassette was obtained after site-specific recombination onto pXL3326 as previously described (16,18).
Two complementary 54mer oligonucleotides were purchased from Eurogentec (Seraing, Belgium): 5"-CAGCTCGGTACCCGGCTCGACATTGACGCAAATGGGCGGTAGGCGTGTACGGTG-3" and 5"-CACCGTACACGCCTACCGCCCATTTGCGTCAATGTCGAGCCGGGTACCGAGCTC-3". They were mixed at 1.35 mg/ml in 10 mM Tris, pH 7.5, and 40 mM NaCl, heated at 95°C for 3 min and annealed by cooling to room temperature.
Bacterial strains and culture conditions
Plasmids pXL3108 and pXL3340 were produced in Escherichia coli DH1 and DH5
cells, respectively (New England Biolabs, Beverly, USA). Plasmid pXL3032 was produced in E.coli XAC-1-pir116, a uidA(
MluI)::pir-116 derivative of XAC-1 (19). Plasmid pXL3178 was obtained in an endA derivative of XACI-pir116 and plasmid pXL3141 was produced in E.coli polA mutant SF800 (10). The minicircle was produced in E.coli D1210HP (16). The antibiotics kanamycin and tetracycline were purchased from Sigma Chemical Co. (Saint Quentin Fallavier, France) and used at 100 and 50 mg/l, respectively, when appropriate.
Plasmid and linearized plasmid preparation
Plasmids were isolated from the different E.coli strains by standard alkaline lysis followed by two cesium chloride/ethidium bromide density gradients (13). Plasmids were first obtained in 10 mM Tris, pH 7.5, and 1 mM EDTA and then lyophilized and resuspended at 1.1 mg/ml in 10 mM Tris, pH 7.5, and 40 mM NaCl.
pXL3032 (3700 bp), pXL3108 (8600 bp) and pXL3340 (19 600 bp) were linearized by cutting 3" to the poly(A) signal with NotI or SalI restriction enzyme. After 1 h incubation at 37°C, linearized plasmids were isolated by phenol/chloroform extraction followed by ethanol precipitation. Linearized plasmids were then resuspended at 100 µg DNA/ml.
HPLC analysis was performed on a Gen-PakTM FAX anion exchange chromatography column (Waters, Saint Quentin Fallavier, France), with a DNA elution gradient of 2.5 mM NaCl/min in 25 mM Tris, pH 8, at 0.75 ml/min.
Endotoxin contaminants, co-purified with plasmid DNA, were estimated by limulus amoebocyte lysate assay (20) to comprise <0.1 EU/mg plasmid in all plasmid preparations except that of pXL3141 (endotoxin value 0.43 EU/mg plasmid).
Cationic lipid preparation, lipoplex formation and size determination
Lipoplyamine RPR120535 and RPR120531 micelles (21) and the lipoplexes they form with DNA were prepared as previously described (4). Bis(guanidinium)-tren-cholesterol (BGTC)/DOPE liposomes and DNA lipoplexes were obtained as previously described (22,23).
Dynamic light scattering measurements of cationic lipidDNA lipoplexes were performed as previously described (4). Particle size was measured using unimodal analysis with an angle of 90° and the particle size distribution using the CONTIN software.
Small angle X-ray scattering
Complexes were prepared as previously described (4). The X-ray scattering experiments were carried out using the synchrotron radiation source DCI of LURE (Orsay, France) on beamline D43. The distance between the sample and detector was 300 mm. A 2-dimensional image plate detector was used. Results are expressed in arbitrary intensity units as a function of q, where q is the momentum transfer q = (4
/
)sin
/2,
the scattering angle and
the X-ray wavelength. q values ranged between 0.05 and 0.30 Å1.
Cryo-transmission electron microscopy (cryo-TEM)
Cryo-TEM experiments were performed as described previously (4). Briefly, RPR120535DNA lipoplexes were prepared at 0.5 mg DNA/ml in 20 mM NaCl, with 7 nmol RPR120535/mg DNA, corresponding to a charge ratio (+/) of 7 and then concentrated by ultrafiltration using 300 K nanosep concentrators (Pall Filtron). RPR120535polyphosphate complexes were prepared at 0.9 mg/ml with a charge ratio (+/) of 6.
Cell culture and in vitro transfection
Murine NIH 3T3 fibroblast and HeLa cells (ATCC, Rockville, USA) were grown at 37°C, 5% CO2 in Dulbeccos modified Eagles medium and minimum essential medium (Gibco BRL, Cergy Pontoise, France) supplemented with penicillin and streptomycin (100 U/ml), L-glutamine (20 mM) and 10% fetal calf serum, respectively. Sodium pyruvate (1 mM) and non-essential amino acids were added to the minimum essential medium. Human aortic smooth muscle cells (AoSMC) (Biowhitaker, Walkerville, USA) were cultured in Smooth Muscle Basal Medium supplemented with 5% fetal bovine serum, human epithelial growth factor (0.5 µg/l), human fibroblast growth factor-B (2 µg/l), amphoptericin B (50 µg/l), insulin (5 mg/l) and gentamycin sulfate (50 mg/l) according to the manufacturers indications. RPR120535DNA lipoplexes (50 µl) containing 0.5 µg of plasmid DNA at a charge ratio (+/) of 6 were added to 500 µl cell culture medium without serum, covering ~75 000 cells in each well of a 24-well dish. Serum (10%) was added to the medium after 3 h transfection. Transfection experiments were performed in quadruplicate. Luciferase activity was assayed 48 h later as previously described (24) using the Luciferase Assay System (Promega Corp., Madison, USA) and a Lumat LB 9501 (Berthold, Evry, France) luminometer. Luciferase activity was related to the protein concentration measured using the Pierce BCA assay (Interchim, Asnieres, France). The variable distribution of luciferase activity was found to correspond to a logarithmically normal distribution and results were given with 95% confidence limits.
| RESULTS |
|---|
|
|
|---|
Plasmid purification and quality control
The five different plasmids, i.e. pXL3032 (3700 bp), pXL3108 (8600 bp), pXL3340 (19 600 bp) and pXL3141 (52 500 bp) and the minicircle, contained the same luciferase expression cassette as described in Materials and Methods. Relaxed forms of the 900, 3700, 8600 and 19 600 bp plasmids were found to correspond to less than 6% of the total DNA preparation, as measured by agarose gel electrophoresis and anionic exchange chromatography. Unfortunately, the relaxed and supercoiled forms of the 52 500 bp pXL3141 could not be separated by HPLC. Therefore, it was difficult to estimate precisely the relaxed pXL3141 content in the DNA preparation. However, agarose gel electrophoresis showed that only a minor fraction of this plasmid preparation was in the relaxed conformation.
Colloidal stability of RPR120535DNA lipoplexes
The stability of the lipoplexes resulting from association of RPR120535 micelles with plasmid DNA resulted in a three zone model of colloidal stability (4). These three zones, termed A, B and C (Fig. 1), were also observed for plasmid DNA lengths ranging from 900 to 19 600 bp. The zones were delimited by the concentration of RPR120535 micelles for a given plasmid DNA concentration. We defined the RPR120535DNA charge ratio (mol positive charges/mol negative charges) as corresponding to 3/2 of the molar ratio (4). In zone A, with a charge ratio ranging from 0 to 1, lipoplexes had a mean diameter of ~180 nm. The lipoplexes in zone B, with a charge ratio of from 1 to 2, were not colloidally stable because a visible precipitate was observed. This precipitate was probably due to a charge ratio close to neutral, which favors the aggregation of lipoplexes by reducing the electrostatic repulsion between them. In zone C, with a charge ratio higher than 2, lipoplexes were found to be colloidally stable, because electrostatic repulsion was present. Note that particle size in zone C was found to be independent of plasmid length, which ranged from 900 to 19 600 bp, and that lipoplex diameters were homogeneous, at around 80 nm. It was interesting to observe that the boundaries between zones A and B and between zones B and C were independent of plasmid length in a 90019 600 bp domain. Size distribution particle analysis revealed that, as previously shown (4), a homogeneous population of individual particles was formed in zone C with mean diameter ranging from 72 to 93 nm.
|
Fluorescence experiments performed by exposing lipoplexes from zone C, obtained with various DNA lengths, to ethidium bromide showed that the fluorescence level was close to 0. This indicated that all DNA molecules were totally incorporated into the lipoplexes, irrespective of the DNA length.
Unlike smaller size plasmid DNA, the 52 500 bp pXL3141 only exhibited, at 0.1 mg DNA/ml, a two zone colloidal stability model with a prolongation of the precipitated zone B, even at a highly positive charge ratio. A visible precipitate was indeed observed, even at a charge ratio of 20 (data not shown). However, at lower DNA concentrations, i.e. the 10 µg DNA/ml which was required for the in vitro transfection experiments, colloidally stable particles from zone C were obtained.
X-ray scattering analysis
Small angle X-ray scattering studies of RPR120535DNA lipoplexes were performed with plasmids ranging from 900 to 52 500 bp. Figure 2A shows the X-ray scans of the 900, 8600 and 52 500 bp plasmids revealing a main peak at q = 0.0767 Å1, which corresponded to ordered domains with a spacing of 82 Å, as expressed by the formula d = 2
/q. Similar X-ray scans were obtained with the other plasmids. Although the exact structure of RPR120535DNA lipoplexes cannot be affirmed from the X-ray scan illustrated in Figure 2A, because of the absence of the second order reflection peak due to the fairly broad first peak, in a previous work structural analysis of these lipoplexes showed a lamellar organization (4). The effective domain size given by the half-width value of the scattering peak was found to be ~300 Å, with extreme values of 260 and 320 Å for the different plasmid DNA lengths. The lipoplexes were thus shown to exhibit a four-lamellar domain independently of plasmid size, within the range 90052 500 bp. From these results, we estimated the number of plasmid molecules contained in one particle, according to our previously published methodology (4). The estimated numbers of plasmid DNA molecules per lipoplex were 55, 17, 13, 6, 2.5 and 0.9 with plasmid sizes of 900, 2900, 3700, 8600, 19 600 and 52 500 bp, respectively.
|
As the length of supercoiled plasmid DNA did not affect particle structure, because a four-lamellar domain with 80 Å spacing was obtained in all cases, we examined the structural features of the complexes resulting from the association of RPR120535 lipopolyamine with linear double-stranded DNA fragments of 54 and 50 000 bp from
phage or with polyphosphate as the anionic backbone. As stated above, the complexes formed with linear fragments exhibited identical diffraction patterns (82 Å spacing and four lamellae) whereas those obtained with the polyphosphate revealed a main, very narrow diffraction peak at d = 79 Å, with reflections observed at d/2, d/3, d/4 and d/5 exhibiting a lamellar organization (Fig. 2B). The effective domain size of the main diffraction peak was >1000 Å, indicating a structure including more than 12 stacked lamellae. Consequently, the molecular structure and/or the charge density of the DNA are essential for the formation of particles characterized by ordered lamellar domains with four lamellae. However, neither the size nor the topological features of the DNA molecules, i.e. whether they are supercoiled or linear, affected this formation We attempted to establish whether the above results were specific to RPR120535DNA lipoplexes or could be extrapolated to lipoplexes obtained with other transfecting cationic lipids. Accordingly, small X-ray scattering was performed with lipoplexes composed of plasmids of different DNA lengths and either the lipopolyamine RPR120531 or BGTC. Interestingly, when plasmid DNA was complexed with either RPR120531 or BGTC cationic lipids, the lipid composition, but not the plasmid DNA size, was found to affect lipoplex supramolecular structure. Ordered lamellar domains with five lamellae and a spacing of 65 Å were obtained after mixing DNA plasmids composed of 90052 500 bp with RPR120531 (data not shown), whereas organized lamellar lipoplexes with four periodicities and a spacing of 70 Å were obtained after mixing the plasmids with BGTC/DOPE (23; data not shown).
Electron microscopy of RPR120535 complexed with DNA and polyphosphate
Cryo-TEM analysis was performed on complexes obtained by combining RPR120535 with plasmids of different sizes, with linear fragments of 54 or 50 000 bp or with polyphosphate. For all plasmids and for linear DNA fragments, complexes with a similar shape and a highly ordered structure were observed. They consisted of ordered microdomains ~50 nm in diameter [fig. 2G in Pitard et al. (4)]. In contrast, lipoplexes composed of RPR120535 and polyphosphate appeared as stretched fibers composed of many lamellae (Fig. 3), in agreement with the results obtained by small angle X-ray scattering (Fig. 2B).
|
In vitro transfection
Note that at the DNA concentration used for in vitro transfection experiments (10 µg DNA/ml), colloidally stable, positively charged particles were obtained with all plasmids, including the 52 500 bp plasmid. The luciferase activity was measured in transfected NIH 3T3, human AoSMC and HeLa cells with the 2900 (minicircle), 3700 (pXL3032), 8600 (pXL3108), 19 600 (pXL3340) and 52 500 bp (pXL3141) plasmids, which all contained the same luciferase expression cassette, associated with RPR120535 micelles to form cationic complexes from zone C.
The transfection activity of RPR120535 micelles associated with plasmid DNA of various lengths was evaluated in NIH 3T3 cells using particles containing only a single copy of the active plasmid, i.e. a plasmid containing one luciferase expression cassette. In order to transfect the cells with the same number of lipoplexes exhibiting the same physicochemical properties, the inactive plasmid pSL301, which contains no reporter gene, was used to fill the particles. Reporter gene expression in NIH 3T3 cells was shown to depend on plasmid length (Fig. 4A). With a 95% confidence interval between 4.5 and 8, luciferase activity was six times greater using the 2900 bp minicircle than it was with the 52 500 bp pXL3141. The same experiment was performed using primary cultures of human AoSMC, which are more refractory to transfection than NIH 3T3 cells. DNA size greatly affected the transfection efficiency of AoSMC cells, because, with a 95% confidence interval of between 17 and 350, the 2900 bp minicircle was shown to be 77 times more efficient than the same molarity of the 52 500 bp pXL3141 (Fig. 4B). Similar results were obtained with other cell lines, i.e. cells derived from the kidney of a male adult African green monkey (CV-1) and from the ascitic fluid of a patient with an ovarian tumor (SK-OV-3) (data not shown).
|
In order to study the impact of the topology of the DNA on the in vitro transfection efficiency, HeLa cells were transfected with identical mass amounts of either plasmid DNA or linearized plasmid DNA. Since the same physicochemical characteristics of lipoplexes were obtained irrespective of DNA length and topology, these conditions resulted in a total number of luciferase expression cassettes per complex which was inversely proportional to the length of the DNA molecule. Note that the same number of lipoplexes per sample were obtained in each condition. The luciferase expression was higher with plasmid DNA than with linearized plasmid DNA (Fig. 5). Similar results have been reported by Zanta et al. (25). The luciferase activities were also dependent on the size of both plasmid DNA and linearized plasmid DNA (Fig. 5). With a 95% confidence interval of between 23 and 92, lipoplexes containing 13 copies of the linearized plasmid DNA (3700 bp) were 50 times more efficient in promoting gene transfer than lipoplexes encapsulating 2.5 copies, i.e. with the same amount of lipoplexes containing five times more of the smaller plasmid, 50 times more transgene expression was detected, suggesting a 10-fold improvement of the transfer efficiency of the smaller plasmid construct.
|
| DISCUSSION |
|---|
|
|
|---|
Although the importance of using a plasmid DNA of minimal size for in vitro transfection activity was recently demonstrated (18), no information was given about lipoplex morphology or structure. Therefore, it was postulated that lipoplexes obtained from the association of cationic lipids with a small plasmid might be smaller than those obtained with larger plasmids. Here, we describe, for the first time as far as we know, the relation between plasmid size, lipoplex physicochemical properties and transfection activity.
In a 90019 600 bp domain, RPR120535DNA lipoplex particles resulted in a three zone model of colloidal stability, irrespective of plasmid size. This stability only depended on the cationic lipidDNA charge ratio (+/). However, stable RPR12053552 500 bp plasmid complexes from zone C could only be obtained at a low DNA concentration (10 µg DNA/ml). DNA of large size might therefore be a limitation for lipoplex-mediated gene transfer, because for clinical applications it is of crucial importance to obtain a DNA solution that is concentrated, homogeneous and colloidally stable.
The structural determination of RPR120535DNA lipoplexes, for a given plasmid DNA length, showed a lamellar organization where DNA molecules were sandwiched between lipid bilayers, irrespective of the cationic lipid/DNA charge ratio (4). The complexation of plasmids with sizes ranging from 900 to 52 500 bp with the lipopolyamine RPR120535 led to the formation of lipoplexes characterized by ordered lamellar domains with four lamellae and a regular spacing of 82 Å, irrespective of plasmid size. This structure was the same for linear double-stranded DNA of 54 and 52 500 bp. On the other hand, complexation of polyphosphate with RPR120535 produced thread-like particles that formed numerous stacked lamellae in which polyphosphate was sandwiched between lipid bilayers, with a regular spacing of 79 Å. Plasmid DNA complexation with another lipopolyamine, RPR120531, or with the cationic lipid BGTC indicated that the cationic lipid determines the spacing of the structure, because a spacing of 65 and 70 Å, respectively, was observed. From all these data, it may be concluded that cationic lipidDNA particle structure and morphology are determined by both the cationic lipid molecule and the DNA backbone. More precisely, we believe that lipoplex structure is the result of competitive interactions between electrostatic forces, i.e. between cationic charges from the lipid and anionic charges from the DNA, on the one hand, and elasticity forces driven by the lipid hydrophobic moiety, on the other.
As DNARPR120535 lipoplex structure and size were not modified by increasing plasmid DNA length, the number of plasmid molecules, and therefore the number of therapeutic gene expression cassettes incorporated into a single lipoplex, increased in a linear fashion as plasmid size decreased. Many studies recently focused on the development, for gene transfer, of virus-like, nanoscopic particles containing only one item of genetic information (26). Here, we found that the in vitro transfection activity of lipoplexes was proportional to the number of expression cassettes in each particle, i.e. the most active lipoplexes were those which exhibited the largest number of plasmid DNA molecules. This result was consistent with that reported by Tseng et al. (27), who recently demonstrated, on a single cell basis, that transgene expression increases with the number of intracellular plasmid copies. A large number of copies may increase the probability that a fraction of the DNA will survive intracellular degradation.
However, the number of reporter gene copies incorporated into lipoplexes cannot alone account for the differences in reporter gene expression observed with plasmids of different sizes. Thus, in the experiment illustrated in Figure 4, in which one coding cassette was inside each particle, the transfection activity of lipoplexes containing smaller plasmids was found to be greater than that of lipoplexes containing the same molarity of larger plasmids.
Baker et al. (28) reported that in order to achieve a transfection efficiency with very large DNA molecules (BACs, >100 kb) comparable to that obtained with conventional plasmid (7 kb), they needed to use an optimized delivery system consisting of PEI and inactivated adenovirus particles. They presumed that these ternary complexes, i.e. DNA/PEI/adenovirus follow some form of the natural adenovirus entry pathway and that the virus may facilitate the delivery of the PEI/DNA complex to the nucleus where the DNA may be dissociated from the PEI. Therefore, the differences in reporter gene activities observed with DNA molecules of various size is highly unlikely to be due to the extra DNA sequence of viral or other origin, but rather to an intracellular phenomenon interfering with the efficiency of expression of large DNA molecules.
The luciferase activities measured in transfected HeLa cells (Fig. 5) were dependent on the size of the plasmid DNA, either supercoiled or linearized. Therefore, the topology of the transfected DNA molecules determines the level of gene expression but small DNA molecules have higher transfection efficiencies than larger ones. The greater transfection efficiency of small plasmids relative to that of larger plasmids may be due to differences in a step of the transfection process which occurs after particle internalization. Szoka et al. (29) recently proposed that endocytosis of cationic lipidDNA complexes destabilizes the endosomal membrane, which results in the displacement of the cationic lipid from the DNA and the subsequent release of DNA in the cytoplasm. Behr et al. (30) also postulated that DNA is released from cationic lipids in the cytoplasm through lipid mixing and competitive exchange with anionic polymers like cytoplasmic mRNA. On the basis of these reports, we suggest that DNA size may account for either the mechanism of DNA release from cationic lipids or for the intracellullar migration of DNA from the cytoplasm to the nucleus, or both. In previous studies (31,32), the authors laid special stress on the importance of the effect of cytoskeletal elements, which act as a sieve on DNA migration into the nucleus. The entry of plasmid DNA into the nucleus required for reporter gene expression may occur during cell division and subsequent disruption of the nuclear envelope. In particular, the highly efficient reporter gene expression obtained here with all plasmids for fast growing NIH 3T3 cells might correlate with cell division. Alternatively, DNA entry into the nucleus can also be achieved within non-dividing cells (33,34). Nuclear entry via the nuclear pores might be dependent on plasmid size. If so, this hypothesis would explain why aortic smooth muscle cell transfection is widely sensitive to plasmid size, as demonstrated by the transfection activity of the minicircle (2900 bp), which was 77 times more efficient than that of pXL3141 (52 500 bp).
A better understanding of the relative importance of both the lipid and plasmid components in lipoplex formation and ultimately in gene delivery efficiency might be useful for the design of improved DNA vectors. Further studies involving the microinjection of DNA molecules of different sizes into the cytoplasm and the nucleus, as well as in vivo transfection experiments, are necessary to improve present knowledge of the intracellular elements involved in plasmid size discrimination.
| ACKNOWLEDGEMENTS |
|---|
The authors thank C. Breda for HPLC analysis, F. Soubrier for assistance in pCOR vector production, G. Byk for RPR120535 and RPR120531 cationic lipid preparation, J.P. Vigneron and J.M. Lehn for providing BGTC and J.C. Daniel, P.G. de Gennes, C. Hélène, A. Mahfoudi and D. Roux for their interest and for stimulating and helpful discussions.
| FOOTNOTES |
|---|
a To whom correspondence should be addressed. Tel: +33 1 55 71 37 72; Fax: +33 1 55 71 28 70; Email: bruno.pitard{at}rp-rorer.fr
| REFERENCES |
|---|
|
|
|---|
- Sternberg,B., Sorgi,F. and Huang,L. (1994) FEBS Lett., 356, 361366.
- Radler,J., Koltover,I., Salditt,T. and Safinya,C. (1997) Science, 275, 810814.
- Lasic,D., Strey,H., Stuart,M., Podgornik,R. and Frederik,P. (1997) J. Am. Chem. Soc., 119, 832833.
- Pitard,B., Aguerre,O., Airiau,M., Lachages,A., Boukhnikachvili,T., Byk,G., Dubertret,C., Herviou,C., Scherman,D., Mayaux,J. and Crouzet,J. (1997) Proc. Natl Acad. Sci. USA, 94, 1441214417.
- Boukhnikachvili,T., Aguerre-Chariol,O., Airiau,M., Lesieur,S., Ollivon,M. and Vacus,J. (1997) FEBS Lett., 409, 188194.
- Eastman,S., Siegel,C., Tousignant,J., Smith,A., Cheng,S. and Scheule,R. (1997) Biochim. Biophys. Acta, 1325, 4162.
- Remy,J., Sirlin,C., Vierling,P. and Behr,J. (1994) Bioconjugate Chem., 5, 647654.
- Noguiez-Hellin,P., Meur,M., Salzmann,J. and Klatzmann,D. (1996) Proc. Natl Acad. Sci. USA, 93, 41754180.
- Mohammadi,S.A. and Hawkins,R.E. (1998) Gene Ther., 5, 7684.
- Crouzet,J., Naudin,L., Orsini,C., Vigne,E., Ferrero,L., Le Roux,A., Benoit,P., Latta,M., Torrent,C., Branellec,D., Denefle,P., Mayaux,J.F., Perricaudet,M. and Yeh,P. (1997) Proc. Natl Acad. Sci. USA, 94, 14141419.
- England,S., Nicholson,L., Johnson,M., Forrest,S., Love,D., Zubrzycka-Gaarn,E.E., Bulman,D., Harris,J. and Davies,K. (1990) Nature, 343, 180182.
- Wells,D., Wells,K., Asante,E., Turner,G., Sunada,Y., Campbell,K., Walsh,F. and Dickson,G. (1995) Hum. Mol. Genet., 4, 12451250.
- Sambrook,J., Fritsh,E. and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
- Soubrier,F., Cameron,B., Manse,B., Somarriba,S., Dubertret,C., Jaslin,G., Jung,G., Le Caer,C., Dang,D., Mouvault,J.M., Scherman,D., Mayaux,J.F. and Crouzet,J. (1999) Gene Ther., in press.
- Tanaka,M. and Herr,W. (1990) Cell, 60, 375386.
- Kreiss,P., Cameron,B., Darquet,A., Scherman,D. and Crouzet,J. (1998) Appl. Microbiol. Biotechnol., 49, 560567.
- Cameron,B., Briggs,K., Pridmore,S., Brefort,G. and Crouzet,J. (1989) J. Bacteriol., 171, 547557.
- Darquet,A., Cameron,B., Wils,P., Scherman,D. and Crouzet,J. (1997) Gene Ther., 4, 13411349.
- Normanly,J., Masson,J., Kleina,L., Abelson,J. and Miller,J. (1986) Proc. Natl Acad. Sci. USA, 83, 65486552.
- Bayston,K. and Cohen,J. (1990) J. Med. Microbiol., 31, 7383.
- Byk,G., Dubertret,C., Escriou,V., Frederic,M., Jaslin,G., Rangara,R., Pitard,B., Crouzet,J., Wils,P., Schwartz,B. and Scherman,D. (1998) J. Med. Chem., 41, 229235.
- Oudrhiri,N., Vigneron,J., Peuchmaur,M., Leclerc,T., Lehn,J. and Lehn,P. (1997) Proc. Natl Acad. Sci. USA, 94, 16511656.
- Pitard,B., Oudrhiri,N., Vigneron,J.P., Hauchecorne,M., Aguerre,O., Toury,R., Airiau,M., Ramasawmy,R., Scherman,D., Crouzet,J., Lehn,J.M. and Lehn,P. (1999) Proc. Natl Acad. Sci. USA, 96, 26212626.
- Cotten,M., Wagner,E. and Birnstiel,M. (1993) Methods Enzymol., 217, 618644.
- Zanta,M.A., Belguise-Valladier,P. and Behr,J.-P. (1999) Proc. Natl Acad. Sci. USA, 96, 9196.
- Blessing,T., Remy,J. and Behr,J. (1998) Proc. Natl Acad. Sci. USA, 95, 14271431.
- Tseng,W., Haselton,F. and Giorgio,T. (1997) J. Biol. Chem., 272, 2564125647.
- Baker,A. and Cotten,M. (1997) Nucleic Acids Res., 25, 19501956.
- Xu,Y. and Szoka,F.J. (1996) Biochemistry, 35, 56165623.
- Labat-Moleur,F., Steffan,A., Brisson,C., Perron,H., Feugeas,O., Furstenberger,P., Oberling,F., Brambilla,E. and Behr,J. (1996) Gene Ther., 3, 10101017.
- Dowty,M., Williams,P., Zhang,G., Hagstrom,J. and Wolff,J. (1995) Proc. Natl Acad. Sci. USA, 92, 45724576
- Lechardeur,D., Sohn,K.-J., Haardt,M., Joshi,P.B., Monck,M., Graham,R.W., Beatty,B., Squire,J., OBrodovich,H. and Lukacs,G.L. (1999) Gene Ther., 6, 482497.
- Dean,D. (1997) Exp. Cell Res., 230, 293302.
-
Pollard,H., Remy,J., Loussouarn,G., Demolombe,S., Behr,J. and Escande,D. (1998) J. Biol. Chem., 273, 75077511.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Desigaux, M. Sainlos, O. Lambert, R. Chevre, E. Letrou-Bonneval, J.-P. Vigneron, P. Lehn, J.-M. Lehn, and B. Pitard Self-assembled lamellar complexes of siRNA with lipidic aminoglycoside derivatives promote efficient siRNA delivery and interference PNAS, October 16, 2007; 104(42): 16534 - 16539. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Falk, T. E. Karlsson, S. Kurdija, J. Frisen, and J. Zupicich High-Throughput Identification of Genes Promoting Neuron Formation and Lineage Choice in Mouse Embryonic Stem Cells Stem Cells, June 1, 2007; 25(6): 1539 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Stavropoulos, R. K. Rowntree, and J. T. Lee Identification of Developmentally Specific Enhancers for Tsix in the Regulation of X Chromosome Inactivation Mol. Cell. Biol., April 1, 2005; 25(7): 2757 - 2769. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bousarghin, A.-L. Combita-Rojas, A. Touze, S. El Mehdaoui, P.-Y. Sizaret, M.-M. Bravo, and P. Coursaget Detection of Neutralizing Antibodies against Human Papillomaviruses (HPV) by Inhibition of Gene Transfer Mediated by HPV Pseudovirions J. Clin. Microbiol., March 1, 2002; 40(3): 926 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Touze, L. Bousarghin, C. Ster, A.-L. Combita, P. Roingeard, and P. Coursaget Gene transfer using human polyomavirus BK virus-like particles expressed in insect cells J. Gen. Virol., December 1, 2001; 82(12): 3005 - 3009. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||









